Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12959433rdf:typepubmed:Citationlld:pubmed
pubmed-article:12959433lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C0001779lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C0027832lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C0332162lld:lifeskim
pubmed-article:12959433lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:12959433pubmed:issue3lld:pubmed
pubmed-article:12959433pubmed:dateCreated2003-9-8lld:pubmed
pubmed-article:12959433pubmed:abstractTextNeurofibromatosis Type 2 (NF2) is an intractable disorder predisposing to multiple, recurrent tumors of the central nervous system (CNS). To clarify the survival rate and characteristics that predict poor survival, we retrospectively reviewed clinical data in cases of NF2.lld:pubmed
pubmed-article:12959433pubmed:languageenglld:pubmed
pubmed-article:12959433pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12959433pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12959433pubmed:statusMEDLINElld:pubmed
pubmed-article:12959433pubmed:monthSeplld:pubmed
pubmed-article:12959433pubmed:issn0022-3085lld:pubmed
pubmed-article:12959433pubmed:authorpubmed-author:YoshidaJunJlld:pubmed
pubmed-article:12959433pubmed:authorpubmed-author:SaitoKiyoshiKlld:pubmed
pubmed-article:12959433pubmed:authorpubmed-author:OtsukaGoroGlld:pubmed
pubmed-article:12959433pubmed:authorpubmed-author:NagataniTetsu...lld:pubmed
pubmed-article:12959433pubmed:issnTypePrintlld:pubmed
pubmed-article:12959433pubmed:volume99lld:pubmed
pubmed-article:12959433pubmed:ownerNLMlld:pubmed
pubmed-article:12959433pubmed:authorsCompleteYlld:pubmed
pubmed-article:12959433pubmed:pagination480-3lld:pubmed
pubmed-article:12959433pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:meshHeadingpubmed-meshheading:12959433...lld:pubmed
pubmed-article:12959433pubmed:year2003lld:pubmed
pubmed-article:12959433pubmed:articleTitleAge at symptom onset and long-term survival in patients with neurofibromatosis Type 2.lld:pubmed
pubmed-article:12959433pubmed:affiliationDepartment of Neurosurgery, Nagoya University, Postgraduate School of Medicine, Nagoya, Japan.lld:pubmed
pubmed-article:12959433pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12959433pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12959433lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12959433lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12959433lld:pubmed